Evidence map›Paper›PMID 36142346›Full record

ArticleInternational journal of molecular sciences2022

Quantitative Correlations between Radiosensitivity Biomarkers Show That the ATM Protein Kinase Is Strongly Involved in the Radiotoxicities Observed after Radiotherapy.

Eymeric Le Reun, Larry Bodgi, Adeline Granzotto, Laurène Sonzogni, Mélanie L Ferlazzo, Joëlle Al-Choboq, Laura El-Nachef, Juliette Restier-Verlet, Elise Berthel, Clément Devic and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 2 countries.

Eymeric Le ReunInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.
Larry BodgiInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.ORCID 0000-0003-1067-9435
Adeline GranzottoInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.
Laurène SonzogniInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.
Mélanie L FerlazzoInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.
Joëlle Al-ChoboqInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.ORCID 0000-0001-6772-6947
Laura El-NachefInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.
Juliette Restier-VerletInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.
Elise BerthelInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.ORCID 0000-0002-7057-1840
Clément DevicInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.ORCID 0000-0002-7622-9886
Audrey BouchetInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.ORCID 0000-0001-7228-8830
Michel BourguignonInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.
Nicolas ForayInserm, U1296 Unit, «Radiation: Defense, Health and Environment», Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.ORCID 0000-0002-1282-1303
Inserm · FR

Funding

Centre National d'Études Spatiales ICARE projectCommissariat Général à l'Investissement INDIRA projectCommissariat Général à l'Investissement INDIRA ProjectFrench-Lebanon partenariat Hubert Curien CEDRE 47880PE projectFrench National Cancer Institute PROUST projectRégion Auvergne Rhone-Alpes ERATOSTHENE projectRégion Auvergne Rhône-Alpes ERATOSTHENE Projectthe French-Lebanon partenariat Hubert Curien CEDRE 47880PE project,
6 · The paper itself

Abstract

Tissue overreactions (OR), whether called adverse effects, radiotoxicity, or radiosensitivity reactions, may occur during or after anti-cancer radiotherapy (RT). They represent a medical, economic, and societal issue and raise the question of individual response to radiation. To predict and prevent them are among the major tasks of radiobiologists. To this aim, radiobiologists have developed a number of predictive assays involving different cellular models and endpoints. To date, while no consensus has been reached to consider one assay as the best predictor of the OR occurrence and severity, radiation oncologists have proposed consensual scales to quantify OR in six different grades of severity, whatever the organ/tissue concerned and their early/late features. This is notably the case with the Common Terminology Criteria for Adverse Events (CTCAE). Few radiobiological studies have used the CTCAE scale as a clinical endpoint to evaluate the statistical robustness of the molecular and cellular predictive assays in the largest range of human radiosensitivity. Here, by using 200 untransformed skin fibroblast cell lines derived from RT-treated cancer patients eliciting OR in the six CTCAE grades range, correlations between CTCAE grades and the major molecular and cellular endpoints proposed to predict OR (namely, cell survival at 2 Gy (SF2), yields of micronuclei, recognized and unrepaired DSBs assessed by immunofluorescence with γH2AX and pATM markers) were examined. To our knowledge, this was the first time that the major radiosensitivity endpoints were compared together with the same cohort and irradiation conditions. Both SF2 and the maximal number of pATM foci reached after 2 Gy appear to be the best predictors of the OR, whatever the CTCAE grades range. All these major radiosensitivity endpoints are mathematically linked in a single mechanistic model of individual response to radiation in which the ATM kinase plays a major role.

Indexed as

Protein KinasesRadiation ToleranceAtaxia Telangiectasia Mutated ProteinsBiomarkersCell SurvivalDNA RepairFibroblastsHumansAtaxia Telangiectasia Mutated ProteinsATM protein, humanBiomarkersProtein KinasesATMDNA double-strand breaksoverreactionspredictive assaysradiosensitivityradiotherapy

Identifiers

PMID36142346
PMCPMC9498991
OpenAlexW4295213563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.